Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome

Hypertension

Volumn 45, Issue 5, 2005, Pages 907-913

  Wang, Ji Guang ^a,b   Staessen, Jan A ^a,e   Franklin, Stanley S ^c   Fagard, Robert ^a   Gueyffier, François ^d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Blood pressure; Clinical trials; Meta analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GUANETHIDINE; PLACEBO; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; STROKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIASTOLE; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS; SYSTOLE;

EID: 18244368464     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000165020.14745.79     Document Type: Article

References (39)

1. Staessen J, Amery A, Fagard R. Editorial review. Isolated systolic hypertension in the elderly. J Hypertens. 1990;8:393-405.
2. Staessen J, O'Brien E, Atkins N, Bulpitt CJ, Cox J, Fagard R, O'Malley K, Thijs L, Amery A. The increase in blood pressure with age and body mass index is overestimated by conventional sphygmomanometry. Am J Epidemiol. 1992;136:450-459.
3. Franklin SS, Gustin WIV, Wong ND, Larson MG, Weber LA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308-315.
4. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, Levy D. Does the relation of blood pressure to coronary heart disease change with aging? The Framingham Heart Study. Circulation. 2001;103:1245-1249.
5. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23:395-401.
6. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, Wang JG, Fagard RH, Safar ME. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med. 2000;160:1085-1089.
7. Kostis JB, Lawrence-Nelson J, Ranjan R, Wilson AC, Kostis WJ, Lacy CR; for the Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. Association of increased pulse pressure with the development of heart failure in SHEP. Am J Hypertens. 2001;14:798-803.
8. Domanski M. Norman J, Wolz M, Mitchell GF, Pfeffer MA. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension. 2001;38:793-797.
9. Domanski M, Mitchell G, Pfeffer M, Neaton JD, Norman J, Svendsen K, Grimm R, Cohen J, Stamler J; for the MRFIT Research Group. Pulse pressure and cardiovascular disease-related mortality. Follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). J Am Med Assoc. 2002;287:2677-2683.
10. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;i:581-583.
11. D'Agostino RB, Belanger AJ, Kannel WB, Cruickshank JM. Relation of low diastolic pressure to coronary heart disease death in the presence of myocardial infarction and: the Framingham study. BMJ. 1991;303:385-389.
12. Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999;159:2004-2009.
13. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865-872.
14. Gueyffier F, Boutitie F, Boissel JP, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Perry HM, Pocock S, Prineas R, Schron E. INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results. Thèrapie. 1995;50:353-362.
15. Amery A, Birkenhäger W, Brixko P, Bulpitt C, Clement D, Deruyttere M, de Schaepdryver A, Dollery C, Fagard R, Forette F, Forte J, Hamdy R, Henry JF, Joossens JV, Leonetti G, Lund-Johansen P, O'Malley K, Petrie J, Strasser T, Tuomiletuo J, Williams B. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancer. 1985:i:1349-1354.
16. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A; for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.
17. Liu L, Wang JG, Gong L, Liu G, Staessen JA; for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo in older patients with isolated systolic hypertension. J Hypertens. 1998;16:1823-1829.
18. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. J Am Med Assoc. 1982;248:1465-1477.
19. Perry HM Jr, McFate Smith W, McDonald RH, Black D, Cutler JA, Furberg CD, Greenlick MR, Kuller LH, Schnaper HW, Schoenberger JA, Vogt TM, Wolf PA, Hulley SB. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) Pilot Study. Stroke. 1989;20:4-13.
20. The Australian therapeutic trial in mild hypertension. Management Committee. Lancet. 1980;1:1261-1267.
21. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. J Am Med Assoc. 1979;242:2562-2571.
22. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ. 1986;293:1145-1151.
23. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ. 1985;291:97-104.
24. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
25. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc. 1991;265:3255-3264.
26. Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients With Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
27. Koch-Weser J. Correlation of pathophysiology and pharmacotherapy in primary hypertension. Am J Cardiol. 1973;32:499-510.
28. Berne RM, MN Levy. Cardiovascular Physiology. St. Louis, Mo: Mosby-Year Book Inc; 1992:135-151.
29. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart. Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection. Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc. 2003;289:2560-2572.
30. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S; for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.
31. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
32. Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000;23(suppl 2):B54-B64.
33. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086-1097.
34. Wright JT, Jr., Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Philips RA, Toto RD, Middleton JP, Rostand SG; for the African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK trial. J Am Med Assoc. 2002;288:2421-2431.
35. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality, a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
36. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP; for the INDANA Project Steering Committee. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med. 2002;136:438-448.
37. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Manda G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P; on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821-848.
38. Duchier J, Iannascoli F, Safar M. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am J Cardiol. 1987;60:99-102.
39. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001;104:1464-1470.